Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin in Methamphetamine-using Men Who Have Sex With Men
NCT02881177Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2017
- Primary completion
- Jul 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in amphetamine use disorder comparing Oxytocin with Placebo (2 arms). Primary endpoint: Side effect profile at 6 weeks. Started Jan 2017; status: completed.
02
Drugs
oxytocin
03
Conditions
amphetamine use disorder
Beyond the preview
Go deeper on NCT02881177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02881177.